U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C23H24N4O4
Molecular Weight 420.4611
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BRENSOCATIB

SMILES

CN1C(=O)OC2=CC=C(C=C12)C3=CC=C(C[C@H](NC(=O)[C@@H]4CNCCCO4)C#N)C=C3

InChI

InChIKey=AEXFXNFMSAAELR-RXVVDRJESA-N
InChI=1S/C23H24N4O4/c1-27-19-12-17(7-8-20(19)31-23(27)29)16-5-3-15(4-6-16)11-18(13-24)26-22(28)21-14-25-9-2-10-30-21/h3-8,12,18,21,25H,2,9-11,14H2,1H3,(H,26,28)/t18-,21-/m0/s1

HIDE SMILES / InChI

Molecular Formula C23H24N4O4
Molecular Weight 420.4611
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Tue Apr 01 20:31:51 GMT 2025
Edited
by admin
on Tue Apr 01 20:31:51 GMT 2025
Record UNII
25CG88L0BB
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AZD-7986
Preferred Name English
BRENSOCATIB
USAN   INN  
Official Name English
brensocatib [INN]
Common Name English
AZD7986
Code English
1,4-OXAZEPINE-2-CARBOXAMIDE, N-((1S)-1-CYANO-2-(4-(2,3-DIHYDRO-3-METHYL-2-OXO-5-BENZOXAZOLYL)PHENYL)ETHYL)HEXAHYDRO-, (2S)-
Systematic Name English
BRENSOCATIB [USAN]
Common Name English
Brensocatib [WHO-DD]
Common Name English
INS1007
Code English
INS-1007
Code English
(S)-N-((S)-1-CYANO-2-(4-(3-METHYL-2-OXO-2,3-DIHYDROBENZO-(D)OXAZOL-5-YL)PHENYL)ETHYL)-1,4-OXAZEPANE-2-CARBOXAMIDE
Systematic Name English
Code System Code Type Description
FDA UNII
25CG88L0BB
Created by admin on Tue Apr 01 20:31:51 GMT 2025 , Edited by admin on Tue Apr 01 20:31:51 GMT 2025
PRIMARY
INN
11097
Created by admin on Tue Apr 01 20:31:51 GMT 2025 , Edited by admin on Tue Apr 01 20:31:51 GMT 2025
PRIMARY
CAS
1802148-05-5
Created by admin on Tue Apr 01 20:31:51 GMT 2025 , Edited by admin on Tue Apr 01 20:31:51 GMT 2025
PRIMARY
DRUG BANK
DB15638
Created by admin on Tue Apr 01 20:31:51 GMT 2025 , Edited by admin on Tue Apr 01 20:31:51 GMT 2025
PRIMARY
PUBCHEM
118253852
Created by admin on Tue Apr 01 20:31:51 GMT 2025 , Edited by admin on Tue Apr 01 20:31:51 GMT 2025
PRIMARY
SMS_ID
300000010203
Created by admin on Tue Apr 01 20:31:51 GMT 2025 , Edited by admin on Tue Apr 01 20:31:51 GMT 2025
PRIMARY
USAN
JK-48
Created by admin on Tue Apr 01 20:31:51 GMT 2025 , Edited by admin on Tue Apr 01 20:31:51 GMT 2025
PRIMARY
NCI_THESAURUS
C171778
Created by admin on Tue Apr 01 20:31:51 GMT 2025 , Edited by admin on Tue Apr 01 20:31:51 GMT 2025
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
TARGET -> INHIBITOR
Information). The interaction could be described with a simple 1:1 interaction model resulting in an on-rate (kon) and an ;-rate (koff) of 4.0 ? 0−3 ;1, giving a pKd value of 8.6. The residence time at the DPP1 enzyme, by half-life, was 3 min.
INHIBITOR
Ki
TARGET -> INHIBITOR
in Vitro Using Differentiating Human Primary Bone Marrow-Derived CD34+ Neutrophil Progenitor Cells
INHIBITOR
IC50
Related Record Type Details
ACTIVE MOIETY